Clinical Trials in New York State

Showing 15241-15260 of 17,167 trials

Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

NCT01308424

The purpose of this study is to determine if a new treatment is effective for the treatment of recurrent symptomatic oral herpes virus infections.

Oral Herpes Simplex

Beech Tree Labs, Inc.171 participantsStarted Jan 2011

Lexington, Kentucky, United States • Buffalo, New York, United States • Norwich, New York, United States +1 more locations

COMPLETEDPhase 269 miles

Lobradimil and Carboplatin in Treating Children With Brain Tumors

NCT00019422

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Lobradimil may increase the effectiveness of a chemotherapy drug by making tumor cells more sensitive to the drug. PURPOSE: Phase II trial to study the effectiveness of carboplatin and lobradimil in treating children with brain tumors that have not responded to previous treatment.

Brain and Central Nervous System Tumors

National Cancer Institute (NCI)Started Mar 1998

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +233 more locations

Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

Lobradimil and Carboplatin in Treating Children With Brain Tumors

Find Trials by Condition in New York State

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Case-Control Viramune (Nevirapine) Toxicogenomics Study

An Open Label Extension Study in Subjects With Fragile X Syndrome

Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

Tolerability Study of Xerecept® in Pediatric Patients

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Study on Interleukin-7 (CYT107) in HIV Patients

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer